Continuous Glucose Monitoring (CGM): Sensor Technology, MARD Accuracy & Wholesale Allocation
Continuous Glucose Monitoring (CGM) has transitioned from an elite Type 1 diabetic tool to the gold standard in Type 2 diabetes and metabolic syndrome therapy. With mean absolute relative difference (MARD) rates falling below 8% in modern factory-calibrated enzyme sensors (FreeStyle Libre 3 and Dexcom G7), fingerstick capillary blood testing is becoming secondary. Medicine Wholesalers manages authorized volume allocations to hospitals and regional retail pharmacy networks.